Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy The following represents disclosure information provided by authors of this manuscript. All ...

Genitourinary cancers require individualized treatment plans based on type, stage, and patient health, utilizing imaging, biopsy, and various therapies. Combining therapies with complementary ...

Austin, May 08, 2025 (GLOBE NEWSWIRE) -- Genitourinary Drugs Market Size & Trends: The global Genitourinary Drugs Market size to reach USD 33.37 billion by 2032, up from USD 29.69 billion in 2024, ...

FORT MYERS, Fla., Feb. 26, 2026 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) advances genitourinary cancer treatment through participation at the global ASCO ® 2026 ...

GSM describes the physical findings and symptoms that are due to decreased estrogen secretion. Estrogen is the most effective therapy for moderate/severe conditions because it rapidly restores ...

Cabometyx combinations showed activity in patients with GU cancers, according to a preliminary clinical study. Genitourinary cancers — particularly urothelial cancer – saw activity with the ...

The North American Menopause Society (NAMS) recently announced the publication of its 2020 Genitourinary Syndrome of Menopause (GSM) position statement that included updated recommendations on the ...

Seattle Cancer Care Alliance (SCCA), UW Medicine, and Fred Hutch physicians and researchers who are leaders in treating genitourinary cancers will attend and present their research at the ...

Prevalence of variant of unknown significance (VUS) in men with prostate cancer who serve as a benchmark for enhanced screening and for personalized therapy. This is an ASCO Meeting Abstract from the ...

Please provide your email address to receive an email when new articles are posted on . Compared with other maternal infections, intestinal infection and genitourinary tract infection increased the ...